Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dermatological Drugs Market 2018, Forecast to 2023

December 2018 | 131 pages | ID: G205763489FEN
GlobalInfoResearch

Abstracts

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.

Scope of the Report:

This report focuses on the Dermatological Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
The worldwide market for Dermatological Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Bayer
• Johnson & Johnson
• Pfizer
• Novartis
• GlaxoSmithKline
• AstraZeneca
• Galderma
• Amgen
• AbbVie
• Merck

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Prescription-Based Drugs
• Over-the-Counter Drugs

Market Segment by Applications, can be divided into

• Acne
• Skin Infections
• Psoriasis
• Dermatitis Drugs
• Other

There are 15 Chapters to deeply display the global Dermatological Drugs market.

Chapter 1, to describe Dermatological Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dermatological Drugs, with sales, revenue, and price of Dermatological Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatological Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dermatological Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dermatological Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Dermatological Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Prescription-Based Drugs
  1.2.2 Over-the-Counter Drugs
1.3 Market Analysis by Applications
  1.3.1 Acne
  1.3.2 Skin Infections
  1.3.3 Psoriasis
  1.3.4 Dermatitis Drugs
  1.3.5 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Bayer
  2.1.1 Business Overview
    2.1.1.1 Bayer Description
    2.1.1.2 Bayer Headquarter, Main Business and Finance Overview
  2.1.2 Bayer Dermatological Drugs Product Introduction
    2.1.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Dermatological Drugs Product Information
  2.1.3 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Bayer Dermatological Drugs Market Share in 2017
2.2 Johnson & Johnson
  2.2.1 Business Overview
    2.2.1.1 Johnson & Johnson Description
    2.2.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
  2.2.2 Johnson & Johnson Dermatological Drugs Product Introduction
    2.2.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Dermatological Drugs Product Information
  2.2.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Johnson & Johnson Dermatological Drugs Market Share in 2017
2.3 Pfizer
  2.3.1 Business Overview
    2.3.1.1 Pfizer Description
    2.3.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.3.2 Pfizer Dermatological Drugs Product Introduction
    2.3.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Dermatological Drugs Product Information
  2.3.3 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Pfizer Dermatological Drugs Market Share in 2017
2.4 Novartis
  2.4.1 Business Overview
    2.4.1.1 Novartis Description
    2.4.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.4.2 Novartis Dermatological Drugs Product Introduction
    2.4.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Dermatological Drugs Product Information
  2.4.3 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Novartis Dermatological Drugs Market Share in 2017
2.5 GlaxoSmithKline
  2.5.1 Business Overview
    2.5.1.1 GlaxoSmithKline Description
    2.5.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
  2.5.2 GlaxoSmithKline Dermatological Drugs Product Introduction
    2.5.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Dermatological Drugs Product Information
  2.5.3 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global GlaxoSmithKline Dermatological Drugs Market Share in 2017
2.6 AstraZeneca
  2.6.1 Business Overview
    2.6.1.1 AstraZeneca Description
    2.6.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
  2.6.2 AstraZeneca Dermatological Drugs Product Introduction
    2.6.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Dermatological Drugs Product Information
  2.6.3 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global AstraZeneca Dermatological Drugs Market Share in 2017
2.7 Galderma
  2.7.1 Business Overview
    2.7.1.1 Galderma Description
    2.7.1.2 Galderma Headquarter, Main Business and Finance Overview
  2.7.2 Galderma Dermatological Drugs Product Introduction
    2.7.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Dermatological Drugs Product Information
  2.7.3 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Galderma Dermatological Drugs Market Share in 2017
2.8 Amgen
  2.8.1 Business Overview
    2.8.1.1 Amgen Description
    2.8.1.2 Amgen Headquarter, Main Business and Finance Overview
  2.8.2 Amgen Dermatological Drugs Product Introduction
    2.8.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Dermatological Drugs Product Information
  2.8.3 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Amgen Dermatological Drugs Market Share in 2017
2.9 AbbVie
  2.9.1 Business Overview
    2.9.1.1 AbbVie Description
    2.9.1.2 AbbVie Headquarter, Main Business and Finance Overview
  2.9.2 AbbVie Dermatological Drugs Product Introduction
    2.9.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Dermatological Drugs Product Information
  2.9.3 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global AbbVie Dermatological Drugs Market Share in 2017
2.10 Merck
  2.10.1 Business Overview
    2.10.1.1 Merck Description
    2.10.1.2 Merck Headquarter, Main Business and Finance Overview
  2.10.2 Merck Dermatological Drugs Product Introduction
    2.10.2.1 Dermatological Drugs Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Dermatological Drugs Product Information
  2.10.3 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Merck Dermatological Drugs Market Share in 2017

3 GLOBAL DERMATOLOGICAL DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Dermatological Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatological Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Dermatological Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Dermatological Drugs Manufacturer Market Share in 2017
  3.4.2 Top 5 Dermatological Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL DERMATOLOGICAL DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Dermatological Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Dermatological Drugs Sales by Regions (2013-2018)
  4.1.2 Global Dermatological Drugs Revenue by Regions (2013-2018)
4.2 North America Dermatological Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Dermatological Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatological Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Dermatological Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatological Drugs Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA DERMATOLOGICAL DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Dermatological Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Dermatological Drugs Sales by Countries (2013-2018)
  5.1.2 North America Dermatological Drugs Revenue by Countries (2013-2018)
  5.1.3 United States Dermatological Drugs Sales and Growth Rate (2013-2018)
  5.1.4 Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
5.2 North America Dermatological Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Dermatological Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Dermatological Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Dermatological Drugs Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Dermatological Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Dermatological Drugs Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Dermatological Drugs Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Dermatological Drugs Revenue and Revenue Share by Application (2013-2018)

6 EUROPE DERMATOLOGICAL DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Dermatological Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Dermatological Drugs Sales by Countries (2013-2018)
  6.1.2 Europe Dermatological Drugs Revenue by Countries (2013-2018)
  6.1.3 Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
  6.1.4 UK Dermatological Drugs Sales and Growth Rate (2013-2018)
  6.1.5 France Dermatological Drugs Sales and Growth Rate (2013-2018)
  6.1.6 Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
  6.1.7 Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Dermatological Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Dermatological Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Dermatological Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Dermatological Drugs Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Dermatological Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Dermatological Drugs Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Dermatological Drugs Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Dermatological Drugs Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC DERMATOLOGICAL DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Dermatological Drugs Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Dermatological Drugs Revenue by Countries (2013-2018)
  7.1.3 China Dermatological Drugs Sales and Growth Rate (2013-2018)
  7.1.4 Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
  7.1.5 Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
  7.1.6 India Dermatological Drugs Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Dermatological Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Dermatological Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Dermatological Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Dermatological Drugs Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Dermatological Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Dermatological Drugs Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Dermatological Drugs Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA DERMATOLOGICAL DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Dermatological Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Dermatological Drugs Sales by Countries (2013-2018)
  8.1.2 South America Dermatological Drugs Revenue by Countries (2013-2018)
  8.1.3 Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
8.2 South America Dermatological Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Dermatological Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Dermatological Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Dermatological Drugs Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Dermatological Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Dermatological Drugs Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Dermatological Drugs Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Dermatological Drugs Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA DERMATOLOGICAL DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Dermatological Drugs Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Dermatological Drugs Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
  9.1.4 UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Dermatological Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Dermatological Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Dermatological Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Dermatological Drugs Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Dermatological Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Dermatological Drugs Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Dermatological Drugs Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL DERMATOLOGICAL DRUGS MARKET SEGMENT BY TYPE

10.1 Global Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Dermatological Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Dermatological Drugs Revenue and Market Share by Type (2013-2018)
10.2 Prescription-Based Drugs Sales Growth and Price
  10.2.1 Global Prescription-Based Drugs Sales Growth (2013-2018)
  10.2.2 Global Prescription-Based Drugs Price (2013-2018)
10.3 Over-the-Counter Drugs Sales Growth and Price
  10.3.1 Global Over-the-Counter Drugs Sales Growth (2013-2018)
  10.3.2 Global Over-the-Counter Drugs Price (2013-2018)

11 GLOBAL DERMATOLOGICAL DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Dermatological Drugs Sales Market Share by Application (2013-2018)
11.2 Acne Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Psoriasis Sales Growth (2013-2018)
11.5 Dermatitis Drugs Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)

12 DERMATOLOGICAL DRUGS MARKET FORECAST (2018-2023)

12.1 Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatological Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Dermatological Drugs Market Forecast (2018-2023)
  12.2.2 Europe Dermatological Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Dermatological Drugs Market Forecast (2018-2023)
  12.2.4 South America Dermatological Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Dermatological Drugs Market Forecast (2018-2023)
12.3 Dermatological Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Dermatological Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
12.4 Dermatological Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Dermatological Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Dermatological Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Dermatological Drugs Picture
Table Product Specifications of Dermatological Drugs
Figure Global Dermatological Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Dermatological Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Dermatological Drugs by Types in 2017
Figure Prescription-Based Drugs Picture
Table Major Manufacturers of Prescription-Based Drugs
Figure Over-the-Counter Drugs Picture
Table Major Manufacturers of Over-the-Counter Drugs
Figure Dermatological Drugs Sales Market Share by Applications in 2017
Figure Acne Picture
Figure Skin Infections Picture
Figure Psoriasis Picture
Figure Dermatitis Drugs Picture
Figure Other Picture
Figure United States Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Bayer Dermatological Drugs Product
Table Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Dermatological Drugs Sales Market Share in 2017
Figure Global Bayer Dermatological Drugs Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Dermatological Drugs Product
Table Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Dermatological Drugs Sales Market Share in 2017
Figure Global Johnson & Johnson Dermatological Drugs Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Pfizer Dermatological Drugs Product
Table Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Dermatological Drugs Sales Market Share in 2017
Figure Global Pfizer Dermatological Drugs Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis Dermatological Drugs Product
Table Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Dermatological Drugs Sales Market Share in 2017
Figure Global Novartis Dermatological Drugs Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Dermatological Drugs Product
Table GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Dermatological Drugs Sales Market Share in 2017
Figure Global GlaxoSmithKline Dermatological Drugs Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Dermatological Drugs Product
Table AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Dermatological Drugs Sales Market Share in 2017
Figure Global AstraZeneca Dermatological Drugs Revenue Market Share in 2017
Table Galderma Headquarter, Established, Main Business and Finance Overview (2017)
Table Galderma Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Galderma Dermatological Drugs Product
Table Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Galderma Dermatological Drugs Sales Market Share in 2017
Figure Global Galderma Dermatological Drugs Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Amgen Dermatological Drugs Product
Table Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Dermatological Drugs Sales Market Share in 2017
Figure Global Amgen Dermatological Drugs Revenue Market Share in 2017
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table AbbVie Dermatological Drugs Product
Table AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Dermatological Drugs Sales Market Share in 2017
Figure Global AbbVie Dermatological Drugs Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Dermatological Drugs Production Bases, Sales Regions and Major Competitors
Table Merck Dermatological Drugs Product
Table Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Dermatological Drugs Sales Market Share in 2017
Figure Global Merck Dermatological Drugs Revenue Market Share in 2017
Table Global Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Global Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table Global Dermatological Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Global Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Global Dermatological Drugs Sales by Regions (2013-2018)
Table Global Dermatological Drugs Sales Market Share by Regions (2013-2018)
Table Global Dermatological Drugs Revenue by Regions (2013-2018)
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2013
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2017
Figure North America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure North America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue and Growth Rate (2013-2018)
Figure North America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table North America Dermatological Drugs Sales by Countries (2013-2018)
Table North America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Sales Market Share by Countries in 2013
Figure North America Dermatological Drugs Sales Market Share by Countries in 2017
Table North America Dermatological Drugs Revenue by Countries (2013-2018)
Table North America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2013
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure United States Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
Table North America Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure North America Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure North America Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table North America Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure North America Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table North America Dermatological Drugs Sales by Type (2013-2018)
Table North America Dermatological Drugs Sales Share by Type (2013-2018)
Table North America Dermatological Drugs Revenue by Type (2013-2018)
Table North America Dermatological Drugs Revenue Share by Type (2013-2018)
Table North America Dermatological Drugs Sales by Application (2013-2018)
Table North America Dermatological Drugs Sales Share by Application (2013-2018)
Table North America Dermatological Drugs Revenue by Application (2013-2018)
Table North America Dermatological Drugs Revenue Share by Application (2013-2018)
Figure Europe Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Europe Dermatological Drugs Sales by Countries (2013-2018)
Table Europe Dermatological Drugs Sales Market Share by Countries (2013-2018)
Table Europe Dermatological Drugs Revenue by Countries (2013-2018)
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2016
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UK Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure France Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
Table Europe Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Europe Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Europe Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Dermatological Drugs Sales by Type (2013-2018)
Table Europe Dermatological Drugs Sales Share by Type (2013-2018)
Table Europe Dermatological Drugs Revenue by Type (2013-2018)
Table Europe Dermatological Drugs Revenue Share by Type (2013-2018)
Table Europe Dermatological Drugs Sales by Application (2013-2018)
Table Europe Dermatological Drugs Sales Share by Application (2013-2018)
Table Europe Dermatological Drugs Revenue by Application (2013-2018)
Table Europe Dermatological Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Dermatological Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue Market Share by Countries 2017
Figure China Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure India Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Dermatological Drugs Sales by Type (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Dermatological Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Dermatological Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales by Application (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Dermatological Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Dermatological Drugs Revenue Share by Application (2013-2018)
Figure South America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table South America Dermatological Drugs Sales by Countries (2013-2018)
Table South America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Sales Market Share by Countries in 2017
Table South America Dermatological Drugs Revenue by Countries (2013-2018)
Table South America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
Table South America Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure South America Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure South America Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table South America Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure South America Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table South America Dermatological Drugs Sales by Type (2013-2018)
Table South America Dermatological Drugs Sales Share by Type (2013-2018)
Table South America Dermatological Drugs Revenue by Type (2013-2018)
Table South America Dermatological Drugs Revenue Share by Type (2013-2018)
Table South America Dermatological Drugs Sales by Application (2013-2018)
Table South America Dermatological Drugs Sales Share by Application (2013-2018)
Table South America Dermatological Drugs Revenue by Application (2013-2018)
Table South America Dermatological Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Dermatological Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Dermatological Drugs Sales by Type (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales by Application (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue Share by Application (2013-2018)
Table Global Dermatological Drugs Sales by Type (2013-2018)
Table Global Dermatological Drugs Sales Share by Type (2013-2018)
Table Global Dermatological Drugs Revenue by Type (2013-2018)
Table Global Dermatological Drugs Revenue Share by Type (2013-2018)
Figure Global Prescription-Based Drugs Sales Growth (2013-2018)
Figure Global Prescription-Based Drugs Price (2013-2018)
Figure Global Over-the-Counter Drugs Sales Growth (2013-2018)
Figure Global Over-the-Counter Drugs Price (2013-2018)
Table Global Dermatological Drugs Sales by Application (2013-2018)
Table Global Dermatological Drugs Sales Share by Application (2013-2018)
Figure Global Acne Sales Growth (2013-2018)
Figure Global Skin Infections Sales Growth (2013-2018)
Figure Global Psoriasis Sales Growth (2013-2018)
Figure Global Dermatitis Drugs Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Regions (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Europe Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Dermatological Drugs Market Forecast (2018-2023)
Figure South America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Dermatological Drugs Market Forecast (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Type (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Application (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List